WASHINGTON — The Supreme Court agreed Wednesday to take on whether Americans can access a commonly used abortion pill.
It will be the court’s first major abortion case since it overturned Roe v. Wade last year, giving jurisdiction over abortion laws back to the states. Since then, 13 states have banned the procedure and seven others have enacted severe limits, though several of those restrictions are in court and voters have spurned others.
The panel will hear arguments this spring and likely issue a decision this summer in the midst of a presidential election that has put abortion rights at the forefront. Its decision could have significant ramifications for the Food and Drug Administration’s regulatory authority.
This article is exclusive to STAT+ subscribers
Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.
Already have an account? Log in
Already have an account? Log in
About the Author Reprints
To submit a correction request, please visit our Contact Us page.
STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect